Early Breast Cancer Fast Facts: Results, Recurrence, Resources

Research Article

Early Breast Cancer Fast Facts: Results, Recurrence, Resources

  • Adrian Hunis *
  • Melisa Hunis

*Corresponding Author: Adrian Hunis, School of Medicine Universidad De Buenos Aires.

Citation: Melisa Hunis, Adrian Hunis, (2023), Early Breast Cancer Fast Facts: Results, Recurrence, Resources, J Clinical Research and Reports, 14(2); DOI:10.31579/2690-1919/346

Copyright: © 2023, Adrian Hunis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 08 December 2023 | Accepted: 19 December 2023 | Published: 27 December 2023

Keywords: endometrial cancer; epidemiology; breast cancer

Abstract

Despite successful treatment, there is always a risk of recurrence in early breast cancer.

The risk of recurrence varies depending on various factors such as the size of the tumor, lymph node involvement, hormone receptor status, and other individual characteristics.

Introduction

  • Early breast cancer refers to cancer that is in its early stages and has not spread to nearby lymph nodes or other parts of the body.
  • Treatment for early breast cancer often includes surgery to remove the tumor, followed by radiation therapy, chemotherapy, hormone therapy, or targeted therapy, depending on the individual case.
  • The prognosis for early breast cancer is generally good, with a high chance of survival if detected and treated early. (Figure 1)

Recurrence:

Despite successful treatment, there is always a risk of recurrence in early breast cancer.

The risk of recurrence varies depending on various factors such as the size of the tumor, lymph node involvement, hormone receptor status, and other individual characteristics.

Regular follow-up appointments, mammograms, and other imaging tests are essential to detect any signs of recurrence early.

Resources:

  • There are numerous resources available for individuals diagnosed with early breast cancer.
    Breast cancer support groups provide emotional support, information, and guidance for patients and their families.’
  • National and international organizations, such as the American Cancer Society, Susan G. Komen, and Breastcancer.org, offer comprehensive information, resources, and helplines for individuals affected by breast cancer.
  • Treatment centers and hospitals often have dedicated breast cancer clinics or departments that provide specialized care and support for patients.
  • Healthcare professionals, including oncologists, surgeons, nurses, and social workers, are valuable resources for information and support throughout the treatment journey.

Detection:

  • Early breast cancer is often detected through routine screening mammograms or by self-examination, where individuals check their breasts for any lumps or changes.
  • Other diagnostic tests, such as ultrasound, MRI, or biopsy, may be used to confirm the diagnosis and gather more information about the tumor.

Treatment Options:

  • Surgery is the primary treatment for early breast cancer. The two main surgical options are breast-conserving surgery (lumpectomy) or mastectomy. The choice depends on the size and location of the tumor, as well as personal preferences.
  • Radiation therapy is commonly recommended after breast-conserving surgery to target any remaining cancer cells and reduce the risk of recurrence.
  • Chemotherapy may be recommended for some cases, particularly when there is a higher risk of the cancer spreading to other parts of the body.
  • Hormone therapy may be prescribed for individuals with hormone receptor-positive breast cancer, which helps to block the effects of hormones on cancer cells.
  • Targeted therapy drugs may be used for specific types of breast cancer, such as HER2-positive breast cancer.

Long-Term Monitoring and Survivorship:

  • After completing treatment, individuals with early breast cancer will have regular follow-up appointments with their healthcare team to monitor for any signs of recurrence or complications.
  • Long-term monitoring may involve regular mammograms, blood tests, and other imaging tests to ensure early detection of any potential recurrence.
  • Survivorship programs and resources are available to help individuals transition into life after treatment and address any physical, emotional, or social challenges they may face.

Additional data on early breast cancer:

  • Early breast cancer is the most common type of breast cancer, accounting for about 80% of all new cases.
  • The five-year survival rate for early breast cancer is around 99% if the cancer is confined to the breast and nearby lymph nodes at the time of diagnosis.
  • The risk of developing breast cancer increases with age, with the majority of cases occurring in women over 50 years old.
  • Family history of breast cancer, certain genetic mutations (such as BRCA1 and BRCA2), early onset of menstruation, late onset of menopause, and hormone replacement therapy are some of the known risk factors for developing breast cancer.
  • Breast cancer can occur in men, although it is rare. Less than 1% of all breast cancer cases occur in men.
  • Regular physical activity, maintaining a healthy weight, limiting alcohol consumption, and breastfeeding may help reduce the risk of developing breast cancer.
  • The development of targeted therapies, such as Herceptin (trastuzumab) and CDK4/6 inhibitors, has significantly improved treatment outcomes for certain types of early breast cancer.
  • Clinical trials play a crucial role in advancing the understanding and treatment of early breast cancer, offering patients access to innovative therapies and treatment approaches.
  • The emotional and psychological impact of a breast cancer diagnosis and treatment can be significant. Seeking support from mental health professionals, support groups, and loved ones can help individuals cope with the challenges they may face.

It's important to note that these data are general and can vary depending on the individual's specific circumstances and the stage and characteristics of their breast cancer.

The diagnosis of early breast cancer typically involves a combination of imaging tests and biopsy. Here is an overview of the diagnostic process:

Diagnosis

The diagnosis of early breast cancer typically involves a combination of imaging tests and biopsy. Here is an overview of the diagnostic process:

  • Screening Mammogram: Routine screening mammograms are often the first step in detecting breast cancer. Mammograms use low-dose X-rays to create detailed images of the breast tissue.
  • Diagnostic Mammogram: If an abnormality is detected on a screening mammogram or if a woman experiences symptoms such as a lump or breast changes, a diagnostic mammogram is performed. This is a more detailed mammogram that focuses on the specific area of concern.
  • Ultrasound: Ultrasound uses sound waves to create images of the breast tissue. It is often used to further evaluate an abnormality found on a mammogram or to determine if a breast lump is solid or fluid-filled.
  • Magnetic Resonance Imaging (MRI): In some cases, an MRI may be recommended to obtain more detailed images of the breast tissue. MRI is particularly useful in assessing the extent of the cancer and determining if it has spread to other areas.
  • Biopsy: A biopsy is the definitive diagnostic test for breast cancer. It involves the removal of a small sample of tissue from the suspicious area in the breast. There are several types of biopsies, including:
  • Fine Needle Aspiration (FNA): A thin needle is used to extract cells or fluid from a lump or abnormal area.
  • Core Needle Biopsy: A larger needle is used to remove a small cylinder of tissue from the suspicious area.
  • Vacuum-Assisted Biopsy: A probe is inserted into the breast and uses suction to collect multiple tissue samples.
  • Surgical Biopsy: In some cases, a surgical procedure may be necessary to remove a larger sample of tissue for further analysis.
  • Pathology Analysis: The biopsy samples are sent to a pathology laboratory, where they are examined under a microscope by a pathologist. The pathologist evaluates the tissue for the presence of cancer cells and determines the type and characteristics of the cancer, such as its stage and hormone receptor status

Staging

Staging is a crucial step in determining the extent and severity of breast cancer. It helps healthcare professionals plan the most appropriate treatment strategy. The staging system commonly used for breast cancer is the TNM system, which stands for Tumor, Node, and Metastasis. Here is an overview of the stages:

Stage 0: Ductal Carcinoma In Situ (DCIS)

The cancer cells are confined to the ducts of the breast and have not invaded surrounding tissue.

Stage I: Early Stage Breast Cancer

  • Stage IA: The tumor measures up to 2 cm in diameter and has not spread to the lymph nodes or other parts of the body.
  • Stage IB: No tumor is found in the breast, but cancer cells are present in the lymph nodes under the arm, which are detected through biopsy.

Stage II: Locally Advanced Breast Cancer

  • Stage IIA: The tumor measures up to 2 cm in diameter and has spread to 1-3 lymph nodes under the arm, or the tumor measures 2-5 cm and has not spread to the lymph nodes.
  • Stage IIB: The tumor measures 2-5 cm and has spread to 1-3 lymph nodes under the arm, or the tumor measures larger than 5 cm but has not spread to the lymph nodes.

Stage III: Locally Advanced Breast Cancer

  • Stage IIIA: The tumor measures any size and has spread to 4-9 lymph nodes under the arm, or the tumor is larger than 5 cm and has spread to 1-3 lymph nodes.
  • Stage IIIB: The tumor has invaded the chest wall or skin and may have spread to 9 or more lymph nodes under the arm, or the tumor has caused swelling or ulceration of the breast skin.
  • Stage IIIC: The tumor has spread to 10 or more lymph nodes under the arm, or has spread to lymph nodes above or below the collarbone.

Stage IV: Metastatic Breast Cancer

The cancer has spread to distant organs, such as the bones, liver, lungs, or brain.

It is important to note that staging also takes into account factors such as hormone receptor status (estrogen and progesterone receptors) and HER2/neu status, as these factors can influence treatment decisions and prognosis.

The staging process involves a combination of physical exams, imaging tests (such as CT scans, bone scans, and PET scans), and sometimes biopsies of other organs to determine if the cancer has spread. A pathologist will analyze the tumor tissue under a microscope to determine the characteristics of the cancer cells, such as their grade (how abnormal they appear) and whether they have certain genetic mutations.

Once the staging process is complete, the healthcare team can develop a personalized treatment plan. Treatment options for breast cancer may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, or a combination of these approaches.

Staging is important for several reasons. It helps determine the prognosis or outlook for the patient, as well as guide treatment decisions. It also allows healthcare professionals to compare treatment outcomes across different groups of patients and conduct research studies to further understand and improve breast cancer treatment.

It's important to note that staging is just one aspect of the overall assessment of breast cancer. Other factors, such as a person's overall health, age, and preferences, are also taken into consideration when developing a treatment plan. It's always best to consult with a healthcare professional who can provide personalized information and guidance based on individual circumstances.

Staging also plays a role in clinical trials and research studies. By categorizing patients into specific stages, researchers can evaluate the outcomes of different treatments or interventions and develop new strategies to improve patient care.

It's important to note that staging is not a one-time process. In some cases, the stage of breast cancer may change over time due to the progression or regression of the disease. Regular follow-up appointments and imaging tests are essential for monitoring any changes and adjusting the treatment plan accordingly.

Subtypes

There are several different subtypes of breast cancer, each with its own unique characteristics and treatment approaches. The most common subtypes include:

  • Hormone receptor-positive (HR+): This subtype of breast cancer is characterized by the presence of hormone receptors, specifically estrogen receptor (ER) and/or progesterone receptor (PR), on the cancer cells. Treatment for HR+ breast cancer often involves hormone therapy, which aims to block or lower the levels of estrogen in the body to prevent cancer growth.
  • Human epidermal growth factor receptor 2-positive (HER2+): In this subtype, the cancer cells have an excess of a protein known as human epidermal growth factor receptor 2 (HER2). Targeted therapies, such as HER2-targeted antibodies or tyrosine kinase inhibitors, are commonly used to treat HER2+ breast cancer
  • Triple-negative breast cancer (TNBC): TNBC is characterized by the absence of hormone receptors (ER and PR) and HER2 expression. It tends to be more aggressive and may require a combination of treatments, such as chemotherapy and radiation therapy.
  • Luminal A and Luminal B: These subtypes are based on gene expression profiling and are associated with different prognoses. Luminal A breast cancer tends to have a better prognosis and is often treated with hormone therapy, while Luminal B breast cancer may require additional treatments, such as chemotherapy.
  • Basal-like breast cancer: This subtype is often referred to as "triple-negative-like" and shares some similarities with TNBC. It is more common in younger women and may have a poorer prognosis. Treatment typically involves a combination of chemotherapy and surgery.

The treatment plan for each subtype of breast cancer is tailored to the specific characteristics of the tumor, including its size, lymph node involvement, and presence of hormone receptors or HER2 expression. It is important for patients to work closely with their healthcare team to determine the most appropriate treatment approach based on their individual subtype and stage of breast cancer.

In addition to the subtypes mentioned above, there are additional subtypes of breast cancer that are less common but still important to consider:

  • Invasive lobular carcinoma (ILC): This subtype accounts for about 10-15% of all breast cancers. ILC begins in the milk-producing glands (lobules) of the breast and tends to spread diffusely within the breast tissue. Treatment for ILC is similar to other types of invasive breast cancer, including surgery, radiation therapy, and systemic therapies such as hormone therapy and chemotherapy.

 

  • Inflammatory breast cancer (IBC): IBC is a rare and aggressive subtype of breast cancer. It is characterized by redness, swelling, and warmth in the breast, often resembling an infection. IBC is usually diagnosed at an advanced stage, and treatment typically involves a combination of chemotherapy, surgery, radiation therapy, and targeted therapies.
  • Paget's disease of the nipple: Paget's disease is a rare type of breast cancer that starts in the ducts of the nipple and spreads to the nipple surface. It often presents with itching, scaling, redness, or crusting of the nipple and is sometimes associated with an underlying ductal carcinoma. Treatment for Paget's disease usually involves surgery, radiation therapy, and systemic therapies as needed.

Each subtype of breast cancer has its own unique characteristics, prognosis, and treatment options. It is crucial for patients to undergo accurate diagnostic testing, such as biopsies and imaging, to determine the specific subtype and stage of their breast cancer. This information is then used by the healthcare team to develop a personalized treatment plan that best addresses the individual patient's needs.

 

Breast Cancer Recurrence

Breast cancer recurrence refers to the return of cancer cells in the breast or nearby lymph nodes after a period of time when the cancer was considered to be in remission or under control. Recurrence can occur locally in the same area as the original tumor, regionally in the nearby lymph nodes, or distantly in other parts of the body, such as the bones, liver, or lungs. 

The risk of breast cancer recurrence varies depending on several factors, including the stage of the original cancer, the subtype of breast cancer, the presence of hormone receptors or HER2 expression, and the effectiveness of the initial treatment. It is important for individuals who have been treated for breast cancer to continue with regular follow-up appointments and screenings to monitor for any signs of recurrence.

The treatment approach for recurrent breast cancer depends on several factors, including the location and extent of the recurrence, the individual's overall health, and the treatments previously received. Some treatment options for recurrent breast cancer may include:

  • Surgery: If the recurrence is localized, surgical removal of the tumor may be an option. This can involve a lumpectomy (removal of the tumor and surrounding tissue) or a mastectomy (removal of the entire breast)
  • Radiation therapy: Radiation therapy may be used to target and kill cancer cells in the area of recurrence, particularly if surgery is not possible or to reduce the risk of local recurrence after surgery
  • Systemic therapy: Systemic treatments, such as chemotherapy, hormone therapy, or targeted therapy, may be used to treat recurrent breast cancer that has spread beyond the original tumor site. The specific treatment approach depends on the subtype of breast cancer and the characteristics of the recurrent tumor
  • Clinical trials: Participation in clinical trials may be an option for individuals with recurrent breast cancer, as it allows access to new and innovative treatments that are not yet widely available.

The treatment plan for recurrent breast cancer is individualized and based on a thorough evaluation of the patient's specific situation. It is important for individuals with recurrent breast cancer to work closely with their healthcare team to determine the most appropriate treatment options and to discuss the potential benefits and risks of each approach.

In addition to the treatment options mentioned above, there are other considerations and strategies that may be employed in managing recurrent breast cancer:

  • Targeted therapies: Depending on the molecular characteristics of the recurrent tumor, targeted therapies may be used. For example, HER2-positive breast cancer may be treated with targeted drugs like trastuzumab (Herceptin) or pertuzumab (Perjeta)
  • Hormone therapy: If the recurrent breast cancer is hormone receptor-positive, hormone therapy may be used to block the effects of estrogen or progesterone on cancer cells. This can include drugs like tamoxifen, aromatase inhibitors, or ovarian suppression.
  • Immunotherapy: Immunotherapy drugs, such as checkpoint inhibitors like pembrolizumab (Keytruda), may be used in certain cases of recurrent breast cancer, particularly those with high levels of tumor-infiltrating lymphocytes
  • Palliative care: In cases where the recurrent breast cancer is advanced and cannot be cured, palliative care may be provided to manage symptoms, improve quality of life, and provide emotional and psychological support.
  • Genetic testing: If not previously done, genetic testing may be recommended for individuals with recurrent breast cancer to assess the presence of inherited gene mutations, such as BRCA1 or BRCA2, which may impact treatment decisions and inform recommendations for family members.
  • Lifestyle modifications: Adopting a healthy lifestyle, including regular exercise, a balanced diet, and stress management, may help improve overall well-being and potentially reduce the risk of cancer recurrence.

It is important for individuals with recurrent breast cancer to have open and ongoing communication with their healthcare team to discuss treatment options, potential side effects, and any concerns or questions they may have. Regular monitoring and follow-up appointments are crucial to detect any signs of further recurrence and to adjust the treatment plan accordingly.

Additional points to consider regarding breast cancer recurrence:

Surveillance and monitoring: Regular follow-up appointments and imaging tests, such as mammograms or PET scans, are typically recommended to monitor for any signs of recurrence. The frequency and type of surveillance will depend on the individual's specific situation and the recommendations of their healthcare team.

Psychological support: Dealing with breast cancer recurrence can be emotionally challenging. It is important for individuals to seek support from loved ones, support groups, or mental health professionals who can provide guidance and help navigate the emotional aspects of recurrence.

  • Second opinions: If an individual is unsure about their treatment plan or wants to explore other options, seeking a second opinion from another healthcare provider can provide a fresh perspective and additional information to make an informed decision.
  • Clinical trials: Participation in clinical trials may be an option for individuals with recurrent breast cancer, as it can provide access to new treatments and contribute to the advancement of medical knowledge.
  • Lifestyle modifications: Adopting a healthy lifestyle, including regular exercise, maintaining a healthy weight, quitting smoking, and reducing alcohol consumption, may help improve overall well-being and potentially reduce the risk of cancer recurrence.

It is important to note that every case of breast cancer recurrence is unique, and the treatment approach will vary depending on individual factors. The most appropriate treatment plan should be determined in consultation with a multidisciplinary healthcare team, including medical oncologists, surgeons, radiation oncologists, and other specialists, who can tailor the approach to the specific needs of the patient.

Of those respondents diagnosed with early-stage breast cancer (Fig. 1)

  • 88% of individuals with stage II EBC and 66% of individuals with stage III EBC will experience distant recurrence, even 20 years after receiving adjuvant endocrine therapy.
  • 68% of respondents say the risk of recurrence is an important consideration in their treatment decision-making process.
  • The majority of respondents wish they had more information about things they can do to potentially prevent recurrence.
  • Many respondents have discussed the topic of recurrence with their healthcare provider (HCP).

It is important to note that these statistics are based on the information provided and may vary depending on individual circumstances and factors. It is always recommended to consult with a healthcare professional for personalized information and guidance regarding breast cancer.

Despite half of participants diagnosed with EBC ever having been on hormonal adjuvant therapy, nearly 2 in 5 (38%) feel their treatment options are limited.

Despite half of the participants diagnosed with EBC having been on hormonal adjuvant therapy, nearly 2 in 5 (38%) feel their treatment options are limited. This suggests that there may be a perception among some individuals that there are not enough treatment options available to them, even after receiving adjuvant therapy. It is important for healthcare providers to address these concerns and provide information about additional treatment options that may be available, such as targeted therapies, immunotherapies, or participation in clinical trials. Open communication between patients and healthcare providers can help ensure that individuals feel empowered to make informed decisions about their treatment and are aware of all available options.

Support and Patient Needs

Support and addressing patient needs are important aspects of the overall care and management of individuals diagnosed with EBC. Here are some considerations related to support and patient needs:

  • Emotional Support: A breast cancer diagnosis can be emotionally challenging. Providing emotional support through counseling, support groups, or therapy can help individuals cope with the emotional impact of their diagnosis and treatment.
  • Information and Education: Many individuals diagnosed with EBC express a desire for more information about their condition, treatment options, and potential side effects. Healthcare providers should ensure that patients have access to accurate and understandable information to help them make informed decisions about their care.
  • Survivorship Care Planning: Developing a survivorship care plan can help individuals transition from active treatment to post-treatment care. This plan should include follow-up care, long-term monitoring, and strategies to address potential late effects or recurrence.
  • Lifestyle and Wellness Support: Encouraging healthy lifestyle choices such as regular exercise, balanced nutrition, and stress management can positively impact overall well-being and potentially reduce the risk of recurrence.
  • Financial and Practical Support: Breast cancer treatment can have financial implications, and individuals may need assistance navigating insurance coverage, managing medical bills, or accessing financial resources. Practical support such as transportation assistance or help with daily tasks can also be beneficial.
  • Shared Decision Making: Engaging patients in shared decision making about their treatment options can enhance their sense of control and involvement in their care. Healthcare providers should ensure that patients' preferences, values, and goals are considered when determining the most appropriate treatment approach.

Addressing these support and patient needs can contribute to improved patient experiences, quality of life, and overall outcomes for individuals diagnosed with EBC. It is important for healthcare providers to have open and ongoing communication with their patients to understand their unique needs and provide appropriate support throughout their treatment journey.

  • Peer Support: Connecting individuals with breast cancer support groups or peer-to-peer mentoring programs can provide a sense of camaraderie and understanding. Peer support allows individuals to share experiences, ask questions, and receive encouragement and advice from others who have gone through a similar journey.
  • Fertility Preservation: For younger individuals diagnosed with EBC who wish to preserve their fertility, discussions about fertility preservation options should be initiated early in the treatment planning process. Referrals to fertility specialists can help individuals explore options such as egg or embryo freezing before undergoing treatments that may affect fertility.
  • Sexual Health Support: Breast cancer treatments can impact sexual health and intimacy. Healthcare providers should address these concerns and provide information on strategies to manage potential side effects, such as vaginal dryness or decreased libido. Referrals to sexual health specialists or counselors may be beneficial in addressing these issues.
  • Survivorship Programs: Survivorship programs or clinics can provide comprehensive care and support for individuals after completing active treatment for EBC. These programs may include regular follow-up visits, survivorship care plans, psychosocial support, and resources to manage long-term side effects or concerns
  • Palliative Care: Palliative care should be integrated early in the treatment journey to provide individuals with EBC relief from symptoms, pain management, and emotional support. Palliative care can be provided alongside curative treatments and is focused on improving overall quality of life.
  • Access to Clinical Trials: Healthcare providers should discuss the possibility of participating in clinical trials with eligible individuals. Clinical trials can offer access to innovative treatments, potentially improving outcomes and expanding treatment options for EBC patients.

Conclusion

In conclusion, providing support and meeting the various needs of individuals diagnosed with early-stage breast cancer is essential for their overall well-being and treatment journey. By addressing emotional, informational, financial, and practical needs, healthcare providers can help patients feel supported and empowered throughout their treatment. Additionally, offering peer support, fertility preservation options, sexual health support, survivorship programs, palliative care, and access to clinical trials can further enhance the care and outcomes for individuals with early-stage breast cancer. By taking a comprehensive approach to care, healthcare providers can ensure that patients receive the support they need to navigate their diagnosis and treatment successfully.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad

Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.

img

Gomez Barriga Maria Dolores

The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.

img

Lin Shaw Chin

Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.

img

Maria Dolores Gomez Barriga

Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.

img

Dr Maria Dolores Gomez Barriga

Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.

img

Dr Maria Regina Penchyna Nieto

Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.

img

Dr Marcelo Flavio Gomes Jardim Filho

Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”

img

Zsuzsanna Bene

Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner

img

Dr Susan Weiner

My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.

img

Lin-Show Chin

My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.

img

Sonila Qirko

My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.

img

Luiz Sellmann